Advertisement

Topics

Auris Health, Inc. Company Profile

09:52 EDT 21st April 2018 | BioPortfolio

Based in Silicon Valley, Auris Health is pioneering the next era of medical intervention by developing platforms that enhance physician capabilities, evolve minimally invasive techniques, and create new categories of care that redefine optimal patient outcomes. The company is committed to transforming medical intervention by integrating robotics, micro-instrumentation, endoscope design, sensing, and data science into one platform. Every element of our technology is driven by patient-specific design aimed at maintaining the integrity of the human body. The company is backed by leading technology investors including Mithril Capital Management, Lux Capital, Coatue Management, and Highland Capital. Learn more at www.aurishealth.com.


News Articles [483 Associated News Articles listed on BioPortfolio]

Auris Health’s Surgical Robot Gets FDA Green Light for Lung Cancer

Auris Health is now the latest surgical robot company with the go-ahead to enter the U.S. market. The Redwood City, CA, based company, formerly known as Auris Surgical Robots, said Friday that its rob...

FDA clears Auris' robotic endoscopy platform

The FDA gave Auris Health clearance for its Monarch robotic endoscopy platform for diagnostic and therapeutic bronchoscopic p -More- 

New failure for Auris in tinnitus trial

The future of Keyzilen, an in-ear injection being developed by Auris Medical Holding in acute inner ear…

‘Unprecedented’ collaboration news not what Auris ordered

On the day after Swiss biotech Auris Medical Holding announced its latest failure in an otolaryngology…

Auris Medical News Release - Auris Medical to Provide Update on Its AM-111 Hearing Loss Program on Thursday, January 4, 2018

Zug, Switzerland, Dec. 28, 2017 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in otolaryn...

Auris Medical gives up on AM-111 trial in sudden deafness

Shares of Swiss biotech firm Auris Medical Holding plunged 48.65% to $0.42 yesterday, after the clinical-stage…

Rapid Test for Emerging C. auris Under Development

If the test is validated in this larger trial, it will enable hospitals to rapidly identify C. auris in patients or the hospital environment.

Be All Ears: Auris To Provide Update On AM-111 On Jan.4

Auris Medical Holding AG (EARS) is slated to provide an update on its development program with AM-111 for the treatment of acute inner ear hearing loss on Thursday, January 4, 2018.

PubMed Articles [3745 Associated PubMed Articles listed on BioPortfolio]

Errata of Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital.

Candida auris, which we described in 2009 (1), has become a global health threat (2). Due to the increasing interest in C. auris, we have received a number of questions regarding this topic. On re-exa...

Persistent Candidemia Despite Appropriate Fungal Therapy: First Case of Candida auris from the United Arab Emirates.

In this case, we report an elderly patient with multiple chronic conditions and prolonged intensive care units (ICU) stay who had recurrent Candida auris (C. auris) in blood despite antifungal therapy...

Approach to the investigation and management of patients with Candida auris, an emerging multidrug-resistant yeast.

Candida auris is an emerging, multidrug-resistant yeast that can spread in healthcare settings. It can cause invasive infections with high mortality and is difficult to identify using traditional yeas...

In vitro efficacy of disinfectants utilised for skin decolonization and environmental decontamination during a hospital outbreak with Candida auris.

Candida auris has caused nosocomial infections and transmissions within hospital settings. As little is known about the efficacy of skin and environmental decontamination products to kill C. auris thi...

Isolation of Candida auris from nine patients in Central America: Importance of accurate diagnosis and susceptibility testing.

Candida auris is an emerging multidrug-resistant (MDR) fungus associated with invasive infections and high mortality. This report describes nine patients from whom C. auris was isolated at a hospital ...

Clinical Trials [2689 Associated Clinical Trials listed on BioPortfolio]

Phase III Open Study, Prospective, Multicenter, Randomized, Comparative to the Positive Control for Evaluating the Efficacy and Safety of Auris-Sedina in the Symptomatic Control of Otalgy in Patients With or Without Acute External Otitis.

To evaluate the efficacy and tolerability of Auris-Sedina in the symptomatic control of otalgy in patients with and without acute external otitis compared with use of Otosynalar®.

Open-Label Study to Evaluate the Efficacy and Safety of SCY-078 in Patients With Candidiasis Caused by Candida Auris (CARES)

This is a multicenter, open-label, non-comparator, single-arm study to evaluate the efficacy, safety, tolerability and PK (pharmacokinetics) of oral SCY-078 as an emergency use treatment f...

Auris Robotic Endoscopy System for Bronchoscopy

In this study, the performance related to the use of the novel Robotic Endoscopy Platform during bronchoscopic procedures will be evaluated.

Trial Embedded in an Electronic Personal Medical Health Records

This is a research study to determine if a personal health record, called myHERO, will help improve health. A personal health record is a secure internet (also called online) tool that con...

Oral Health Literacy Tailored Communication

The purpose of this study to investigate attitude, oral health literacy and psychological factors in order to evaluate if these factors are important for oral health in adults. The hypoth...

Companies [1746 Associated Companies listed on BioPortfolio]

Auris Health, Inc.

Based in Silicon Valley, Auris Health is pioneering the next era of medical intervention by developing platforms that enhance physician capabilities, evolve minimally invasive tec...

Innovation Health

Innovation Health provides health benefit plans to more than 200,000 members. The product of a unique Aetna and Inova Health System partnership, Innovation Heal...

Health Net Foundation

Based in Woodland Hills, Calif., the Health Net Foundation was created in 2007 as a philanthropic arm of Health Net, Inc. (NYSE: HNT), one of the nation’s largest publicly tr...

Health Net Community Solutions, Inc. and CalViva Health

Health Net Community Solutions, Inc. is a subsidiary of Health Net of California, Inc., which is a subsidiary of Health Net, Inc. (NYSE: HNT) and one of the largest health plans i...

Network Health

Since 1997, Network Health has provided Massachusetts residents with low and moderate incomes access to high-quality health care. Based in Medford, Mass., Network Health is a comp...

More Information about "Auris Health, Inc." on BioPortfolio

We have published hundreds of Auris Health, Inc. news stories on BioPortfolio along with dozens of Auris Health, Inc. Clinical Trials and PubMed Articles about Auris Health, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Auris Health, Inc. Companies in our database. You can also find out about relevant Auris Health, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record